Cargando…

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management

Multidrug-resistant tuberculosis (MDR-TB)/rifampicin-resistant TB (RR-TB) is human-made problem and emerging due to poor management of TB and is a threat to control of TB. Early suspicion and diagnosis are important. Culture and drug susceptibility testing are gold standards, but newer molecular met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prasad, Rajendra, Gupta, Nikhil, Banka, Amitabh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Postgraduate Education Desk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760876/ https://www.ncbi.nlm.nih.gov/pubmed/29319042 http://dx.doi.org/10.4103/lungindia.lungindia_98_17

Ejemplares similares

Ethics in writing: Learning to stay away from plagiarism and scientific misconduct
por: Sharma, Bharat Bhushan, et al.
Publicado: (2011)

Severe acute respiratory syndrome-coronavirus 2 and novel coronavirus disease 2019: An extraordinary pandemic
por: Singh, Sheetu, et al.
Publicado: (2020)

Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope
por: Prasad, Rajendra, et al.
Publicado: (2017)

Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
por: Prasad, Rajendra, et al.
Publicado: (2017)

Egg and banana sign of severe pulmonary arterial hypertension
por: Veean, Satyam, et al.
Publicado: (2018)

Authorship issues
por: Bavdekar, Sandeep B.
Publicado: (2012)

2025 too short time to eliminate tuberculosis from India
por: Prasad, Rajendra, et al.
Publicado: (2017)

Pharmacotherapy for multidrug resistant tuberculosis
por: Chhabra, Naveen, et al.
Publicado: (2012)

Pulmonary hamartoma with tuberculosis masquerading as metastasis
por: Jindal, Tarun, et al.
Publicado: (2011)

Skin lesions in a 30-year-old male having smear-positive pulmonary tuberculosis
por: Gupta, Prem P., et al.
Publicado: (2009)

In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Postgraduate Educational Programme
Publicado: (2009)

Prevalence and factors associated with multidrug/rifampicin resistant tuberculosis among suspected drug resistant tuberculosis patients in Botswana
por: Tembo, Blackson Pitolo, et al.
Publicado: (2019)

Treatment of Infection as a Core Strategy to Prevent Rifampicin-Resistant/Multidrug-Resistant Tuberculosis
por: Reuter, Anja, et al.
Publicado: (2023)

Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China
por: Zhao, Bing, et al.
Publicado: (2022)

A rare case of sarcoidosis with necrotizing mediastinal lymphadenitis misdiagnosed as multidrug-resistant tuberculosis (MDR- TB)
por: Prasad, Rajendra, et al.
Publicado: (2022)

Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management
por: Prasad, Rajendra, et al.
Publicado: (2017)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa
por: Salaam-Dreyer, Zubeida, et al.
Publicado: (2021)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Frequency distribution
por: Manikandan, S
Publicado: (2011)

Measures of central tendency: Median and mode
por: Manikandan, S.
Publicado: (2011)

Measures of central tendency: The mean
por: Manikandan, S.
Publicado: (2011)

Preparing to analyse data
por: Manikandan, S
Publicado: (2010)

Measures of dispersion
por: Manikandan, S.
Publicado: (2011)

Data transformation
por: Manikandan, S
Publicado: (2010)

QT prolongation and torsades de pointes with psychotropic agents
por: Desai, Nagaraj, et al.
Publicado: (2015)

Validation of an indigenous assay for rapid molecular detection of rifampicin resistance in presumptive multidrug-resistant pulmonary tuberculosis patients
por: Gomathi, N.S., et al.
Publicado: (2020)

Rifampicin Resistance in Tuberculosis Outbreak, London, England
por: Jenkins, Claire, et al.
Publicado: (2005)

Chylothorax in a child with rifampicin-resistant tuberculosis
por: McLaren, B, et al.
Publicado: (2019)

Navigating a Path to Rifampicin Resistance in Tuberculosis
por: Agarwal, Sakshi, et al.
Publicado: (2023)

Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosis
por: Choi, Hongjo, et al.
Publicado: (2023)

Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives
por: Singh, Abhijeet, et al.
Publicado: (2020)

Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies
por: Prasad, R.
Publicado: (2012)

Health-Related Quality of Life in Tuberculosis Patients in Eritrea: Comparison Among Drug-Susceptible and Rifampicin/Multidrug-Resistant Tuberculosis Patients
por: Araia, Zenawi Zeramariam, et al.
Publicado: (2021)

Knowledge, Attitude, and Practices Among Healthcare Practitioners in the Context of Multidrug Resistance Tuberculosis: An Appraisal to Disease Elimination
por: Jain, Mantu, et al.
Publicado: (2023)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m2oveglh545n727arq97ttkhpu